European Primary Care Cardiovascular Society

Better insight into current daily clinical practice and more collaboration is needed to improve diabetes care

3' education - Oct. 8, 2019 - Prof. Chantal Mathieu

Why we need updated Diabetes Guidelines and new recommendations

5' education - Oct. 8, 2019 - Prof. Francesco Cosentino - European Diabetes Policy Summit

Policy recommendations to stimulate implementation of diabetes guidelines

5' education - Oct. 8, 2019 - Prof. Cornelia Bala - European Diabetes Policy Summit

Implementation of guidelines: identifying barriers

5' education - Oct. 8, 2019 - Prof. Roger Lehmann - European Diabetes Policy Summit

Old anti-inflammatory drug successfully repurposed for a new application

3' education - Nov. 16, 2019 - Aruna Pradhan, Boston - AHA 2019, Philadelphia

Anti-inflammatory agent reduces both first and recurrent events post-MI

3' education - Dec. 19, 2019 - Jean-Claude Tardif, Montreal - AHA 2019, Philadelphia

SGLT2i gives consistent CV benefit and tolerability in HF patients irrespective of diabetes

3' education - Nov. 16, 2019 - John McMurray, Glasgow - AHA 2019, Philadelphia

Fish oil may give favorable effects on plaque-parameters

3' education - Nov. 17, 2019 - Stephen Nicholls, Melbourne - AHA 2019, Philadelphia

A generation of teenagers is made addicted to nicotine: AHA stands up against 'big vape'

3' education - Nov. 17, 2019 - Mariell Jessup, Dallas - AHA 2019, Philadelphia

ARNI seems to give CV benefit up to EF of about 60%, not only in HFrEF

3' education - Nov. 16, 2019 - Scott Solomon, Boston - AHA 2019, Philadelphia

Does HF have two physiologies that respond differently to treatment, or is it the same disease across the EF spectrum?

3' education - Nov. 18, 2019 - Lynne Stevenson, Nashville - AHA 2019, Philadelphia

SGLT2 inhibitor improves health status in HFrEF

3' education - Nov. 17, 2019 - Mikhail Kosiborod, Kansas City - AHA 2019, Philadelphia

Several plaque parameters reduced after 9 months of fish oil treatment

3' education - Nov. 17, 2019 - Matthew Budoff, Los Angeles - AHA 2019, Philadelphia
EPCCS Annual CV Summit

Heart failure and comorbidities: kidney disease and cancer

5' education - Mar. 22, 2019 - Lisbon, Portugal - Peter van der Meer & Monika Hollander

EPCCS and primary CV care in Poland (Polish)

3' education - Nov. 4, 2019 - Pawel Zuk - EPCCS Council 2019, Bucharest

EPCCS and primary CV care in Poland (English)

3' education - Sep. 13, 2019 - Pawel Zuk - EPCCS 2019, Bucharest

EPCCS and primary CV care in Ukraine

3' education - Sep. 13, 2019 - Maryna Dolzhenko - EPCCS Council 2019

EPCCS and primary CV care in France

3' education - Sep. 13, 2019 - Didier Duhot - EPCCS Council 2019

EPCCS and primary CV care in Ireland

3' education - Sep. 13, 2019 - Cormac Ó Dubhghaill - EPCCS 2019, Bucharest

EPCCS and primary CV care in Turkey

3' education - Sep. 13, 2019 - Zehra Dagli - EPCCS Council 2019, Bucharest

Lower CV and CHD risk with higher olive oil consumption in US adults

Literature - Mar. 25, 2020 - Guasch-Ferré M et al., - J Am Coll Cardiol. 2020.

In an analysis of two large U.S. cohorts, higher olive oil intake was associated with lower risk of a composite of major CVD and CHD risk compared to those consuming olive oil <1 per month.

The COVID-19 pandemic and CV considerations

News - Mar. 25, 2020

A review article published in JACC outlines CV considerations for patients, health care workers, and health systems during the coronavirus disease 2019 (COVID-19) pandemic.

Increased risk of CVD with irregular sleep duration and timing

Literature - Mar. 25, 2020 - Huang T et al., - J Am Coll Cardiol. 2020.

Using data from the MESA study, it was demonstrated that individuals with irregular sleep duration and timing have increased risk of CVD.

Implications of coronaviruses on the cardiovascular system

Literature - Mar. 19, 2020 - Xiong TY, et al. - Eur Heart J. 2020

This viewpoint article draws attention towards acute and possible long-term implications of coronavirus infections, such as COVID-19, on the cardiovascular system.

Continued ACEi and ARBs use in relation to coronavirus COVID-19 outbreak: an ESC statement

News - Mar. 16, 2020

The ESC Council on Hypertension has released a statement, strongly recommending to continue treatment of ACEi and ARBs in times of the COVID-19 pandemic, as evidence for harmful effects of these drugs in context of COVID-19 is lacking.

Reduced BP in South Asian hypertensic adults with community-based intervention

Literature - Mar. 10, 2020 - Jafar TH et al., - N Engl J Med. 2020.

A community-based multicomponent intervention led to a greater reduction in BP than usual care among adults with hypertension in rural communities in three South Asian countries.

Coronavirus COVID-19 clinical guidance for CV care team issued by ACC

News - Mar. 10, 2020

The ACC has released a clinical bulletin providing literature on acute cardiac complications of COVID-19, implications for CV patients and clinical guidance and recommendations for cardiac-specific preparedness.

Integrated care for elderly patients with AF can be safely organized in primary care

Literature - Mar. 9, 2020 - Van den Dries CJ et al., - Eur Heart J. 2020.
This cluster randomized, non-inferiority trial showed that integrated care for elderly AF patients in a primary care setting led to a 45% reduction in all-cause mortality compared with usual care.

This cluster randomized, non-inferiority trial showed that integrated care for elderly AF patients in a primary care setting led to a 45% reduction in all-cause mortality compared with usual care.

Screening and management of CAD patients with dysglycemia needs to be improved

Literature - Mar. 5, 2020 - Ferrannini G et al., - Diabetes Care 2020

An analysis of the EUROASPIRE V survey showed that dysglycemia in CAD patients was unrecognized in a large portion of patients, while two thirds of CAD patients have T2DM or IGT.

Sugar-sweetened beverage intake associated with adverse changes in HDL-c and triglycerides

Literature - Mar. 5, 2020 - Haslam DE et al., - J Am Heart Assoc. 2020.

High intake of sugar-sweetened beverages was associated with adverse changes in HDL-c and triglyceride, along with higher incidence of dyslipidemias related to low HDL-c and high triglyceride.

Higher levels of cardiometabolic markers associated with sitting behavior in postmenopausal women

Literature - Mar. 4, 2020 - Chang YJ et al., - J Am Heart Assoc. 2020.

This multi-cohort study of Hispanic and non-Hispanic overweight/obese postmenopausal women shows that sitting behavior is deleteriously associated with higher levels of cardiometabolic risk biomarkers.

Key biological mechanisms of LDL-c leading to ASCVD in EAS Consensus Statement

News - Mar. 3, 2020

The Consensus Panel of the European Atherosclerosis Society has published a statement on key biological mechanisms that underlie the central role of LDL in the pathophysiology of ASCVD.